ERBB2 and breast lobular carcinoma: Interestingly, a similar rate of ERBB2 mutations was previously reported in a smaller series by Lien and colleagues, who identified ERBB2 mutations in five out of 24 (21%) invasive and in-situ pleomorphic lobular carcinomas [24].